𝔖 Bobbio Scriptorium
✦   LIBER   ✦

847 Identification of a Biomarker Signature to Predict the Need for Chemotherapy in Patients With Hormone Receptor Positive Breast Cancer

✍ Scribed by U. Korf; J. Sonntag; C. Bender; S. Wiemann; S. Aulmann; P. Sinn; B. Burwinkel; A. Schneeweiss; T. Beissbarth

Book ID
117663313
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
68 KB
Volume
48
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

5005 ORAL Exploratory Subgroup Analysis
5005 ORAL Exploratory Subgroup Analysis of the TAMRAD Phase 2 GINECO Trial Comparing Tamoxifen (TAM) Plus Everolimus (RAD) With TAM Alone in Patients With Hormone-receptor-positive, HER2-negative Metastatic Breast Cancer (mBC) With Prior Exposure to Aromatase Inhibitors (Als): Implication for Research Strategies
✍ Bourqier, C.; Ray-Coquard, I.; Provencal, J.; Cropet, C.; Bourcier, A.V.; Delecr πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 43 KB
NSABP B-42: A Clinical Trial to Determin
NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptorβ€”Positive Breast Cancer
✍ Eleftherios P. Mamounas; Barry Lembersky; Jong-Hyeon Jeong; Walter Cronin; Barba πŸ“‚ Article πŸ“… 2006 πŸ› CIG Media Group, LP. 🌐 English βš– 117 KB